RIGL20260717C41
RIGL Jul 17 2026 41.00 Call (RIGL260717C00041000)
option OPRA

rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.